190 related articles for article (PubMed ID: 9685399)
1. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer.
Engelman JA; Lee RJ; Karnezis A; Bearss DJ; Webster M; Siegel P; Muller WJ; Windle JJ; Pestell RG; Lisanti MP
J Biol Chem; 1998 Aug; 273(32):20448-55. PubMed ID: 9685399
[TBL] [Abstract][Full Text] [Related]
2. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain.
Engelman JA; Chu C; Lin A; Jo H; Ikezu T; Okamoto T; Kohtz DS; Lisanti MP
FEBS Lett; 1998 May; 428(3):205-11. PubMed ID: 9654135
[TBL] [Abstract][Full Text] [Related]
3. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities.
Couet J; Sargiacomo M; Lisanti MP
J Biol Chem; 1997 Nov; 272(48):30429-38. PubMed ID: 9374534
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation.
Galang CK; García-Ramírez J; Solski PA; Westwick JK; Der CJ; Neznanov NN; Oshima RG; Hauser CA
J Biol Chem; 1996 Apr; 271(14):7992-8. PubMed ID: 8626480
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo.
Li S; Seitz R; Lisanti MP
J Biol Chem; 1996 Feb; 271(7):3863-8. PubMed ID: 8632005
[TBL] [Abstract][Full Text] [Related]
6. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity.
Muthuswamy SK; Siegel PM; Dankort DL; Webster MA; Muller WJ
Mol Cell Biol; 1994 Jan; 14(1):735-43. PubMed ID: 7903421
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor-stimulated tyrosine phosphorylation of caveolin-1. Enhanced caveolin-1 tyrosine phosphorylation following aberrant epidermal growth factor receptor status.
Kim YN; Wiepz GJ; Guadarrama AG; Bertics PJ
J Biol Chem; 2000 Mar; 275(11):7481-91. PubMed ID: 10713051
[TBL] [Abstract][Full Text] [Related]
9. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases.
Li S; Couet J; Lisanti MP
J Biol Chem; 1996 Nov; 271(46):29182-90. PubMed ID: 8910575
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
11. Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation.
Zrihan-Licht S; Deng B; Yarden Y; McShan G; Keydar I; Avraham H
J Biol Chem; 1998 Feb; 273(7):4065-72. PubMed ID: 9461599
[TBL] [Abstract][Full Text] [Related]
12. p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras-MAP kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity.
Engelman JA; Zhang XL; Razani B; Pestell RG; Lisanti MP
J Biol Chem; 1999 Nov; 274(45):32333-41. PubMed ID: 10542274
[TBL] [Abstract][Full Text] [Related]
13. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors.
Siegel PM; Dankort DL; Hardy WR; Muller WJ
Mol Cell Biol; 1994 Nov; 14(11):7068-77. PubMed ID: 7935422
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A.
Razani B; Rubin CS; Lisanti MP
J Biol Chem; 1999 Sep; 274(37):26353-60. PubMed ID: 10473592
[TBL] [Abstract][Full Text] [Related]
15. Prolactin negatively regulates caveolin-1 gene expression in the mammary gland during lactation, via a Ras-dependent mechanism.
Park DS; Lee H; Riedel C; Hulit J; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2001 Dec; 276(51):48389-97. PubMed ID: 11602600
[TBL] [Abstract][Full Text] [Related]
16. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.
Dankort D; Maslikowski B; Warner N; Kanno N; Kim H; Wang Z; Moran MF; Oshima RG; Cardiff RD; Muller WJ
Mol Cell Biol; 2001 Mar; 21(5):1540-51. PubMed ID: 11238891
[TBL] [Abstract][Full Text] [Related]
17. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
Bai T; Luoh SW
Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
[TBL] [Abstract][Full Text] [Related]
18. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.
Muthuswamy SK; Muller WJ
Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608
[TBL] [Abstract][Full Text] [Related]
19. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
20. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
Kim A; Liu B; Ordonez-Ercan D; Alvarez KM; Jones LD; McKimmey C; Edgerton SM; Yang X; Thor AD
Breast Cancer Res; 2005; 7(5):R708-18. PubMed ID: 16168116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
